`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`INNOPHARMA LICENSING, INC., INNOPHARMA LICENSING LLC,
`INNOPHARMA INC., INNOPHARMA LLC,
`MYLAN PHARMACEUTICALS INC., and MYLAN INC.
`Petitioner,
`
`v .
`
`SENJU PHARMACEUTICAL CO., LTD., BAUSCH & LOMB, INC., and
`BAUSCH & LOMB PHARMA HOLDINGS CORP.
`Patent Owner.
`__________________
`
`Case IPR2015-00902 (Patent 8,669,290 B2)
`Case IPR2015-00903 (Patent 8,129,431 B2)1
`__________________
`
`BEFORE FRANCISCO C. PRATS, ERICA A. FRANKLIN, and GRACE
`KARAFFA OBERMANN, Administrative Patent Judges
`
`PROPOSED SCHEDULING ORDER
`PURSUANT TO ORDER 9
`
`1 The word-for-word identical paper is filed in each proceeding identified in the
`heading.
`
`
`
`IPR2015-00902 (Patent 8,669,290)
`IPR2015-00903 (Patent 8,129,431)
`
`InnoPharma Licensing Inc., InnoPharma Licensing LLC, InnoPharma Inc.,
`
`InnoPharma LLC, Mylan Pharmaceuticals Inc., and Mylan Inc. (collectively
`
`“InnoPharma”) hereby respectfully submits this Proposed Scheduling Order in
`
`accordance with the Board’s Order entered April 17, 2015. (Paper Nos. 9, 9).2
`
`InnoPharma’s Proposed Scheduling Order would extend the currently
`
`schedule date for oral argument in the Metrics IPR Nos. 2014-01041 and 2014-
`
`01043 minimally.
`
`See 35 U.S.C. § 316(a)(1); 37 C.F.R. § 42.100(c). The
`
`proposed extension should cause minimal prejudice to Metrics, Inc., Mayne
`
`Pharma,
`
`and Johnson Matthey,
`
`Inc.
`
`(collectively,
`
`“Metrics”) or Senju
`
`Pharmaceutical Co., Ltd., Bausch & Lomb, Inc., and Bausch & Lomb Pharma
`
`Holdings Corp. (collectively “Senju”).
`
`2 Unless otherwise specified, citations to the paper numbers refer to filings and
`orders in IPR2015-00902 and IPR2015-00903, respectively.
`
`1
`
`
`
`IPR2015-00902 (Patent 8,669,290)
`IPR2015-00903 (Patent 8,129,431)
`
`IPR2014-01041 &
`01043
`June 26, 2014
`November 20, 2014
`
`February 19, 2015
`
`N/A
`
`IPR2015-00902 & 00903
`(proposed schedule)
`N/A
`
`March 19, 2015
`March 19, 2015
`
`May 19, 2015
`
`May 26, 2015
`
`May 26, 2015
`
`June 9, 2015
`
`Dates
`
`Petition date (Metrics)
`PO preliminary response to
`Metrics petition
`Decision of institution on
`Metrics petition
`Petition date (InnoPharma)
`Motion for joinder by
`InnoPharma
`InnoPharma to file proposed
`scheduling order
`PO preliminary response to
`InnoPharma petition
`
`PO opposition to motion for
`joinder
`Metrics opposition to
`InnoPharma motion for joinder
`and proposed scheduling order
`InnoPharma consolidated reply
`to opposition to motion for
`joinder
`
`2
`
`
`
`IPR2015-00902 (Patent 8,669,290)
`IPR2015-00903 (Patent 8,129,431)
`
`IPR2014-01041 &
`01043
`
`IPR2015-00902 & 00903
`(proposed schedule)
`July 27, 20153,4
`
`June 26, 2015
`
`September 25, 2015
`
`September 18, 2015 November 25, 2015
`
`Dates
`
`Decision of institution on
`InnoPharma petition
`
`Ruling on motion for joinder
`PO’s response to the petition
`
`PO’s motion to amend the
`patent
`
`(Due Date 1)
`Petitioner’s reply to PO’s
`response to petition
`
`Opposition to motion to amend
`
`(Due Date 2)
`
`3 See EX2001, Transcript of Teleconference dated April 15, 2015, 36:15-37:1 (the
`
`Board explaining to the parties that although the Decision to Institute is due on
`
`August 26, the Board was willing to get it out earlier, so long as it was not before
`
`June 26th (“I could get them out earlier if we propose a schedule where I have to
`
`get the decisions to institute -- I don't see myself getting them out before June
`
`26th.”)).
`
`4 In the event the Board issues its Decision to Institute on August 26, then
`
`InnoPharma proposes that all of the corresponding dates will be pushed back by
`
`one month (with accommodations made if a Due Date falls on a weekend or a
`
`Federal Holiday).
`
`3
`
`
`
`IPR2015-00902 (Patent 8,669,290)
`IPR2015-00903 (Patent 8,129,431)
`
`IPR2014-01041 &
`01043
`October 8, 2015
`
`IPR2015-00902 & 00903
`(proposed schedule)
`December 21, 20155
`
`October 8, 2015
`
`December 21, 2015
`
`October 22, 2015
`
`January 7, 2016
`
`October 29, 2015
`
`January 14, 2016
`
`November 12, 2015
`
`January 21, 2016
`
`Dates
`
`PO’s Reply to Petitioner’s
`opposition to motion to amend
`
`(Due Date 3)
`Motion for observation
`regarding cross-examination of
`reply witness
`
`Motion to exclude evidence
`
`Request for oral argument
`
`(Due Date 4)
`Response to observation
`
`Opposition to motion to
`exclude
`
`(Due Date 5)
`Reply to opposition to motion
`to exclude
`
`(Due Date 6)
`Oral argument (if requested)
`
`(Due Date 7)
`
`5 Due Date 3 and Due Date 4 fall on the same date, similar to the stipulation
`between Metrics and Senju in IPR Nos. 2014-01041 and 2014-01043, Paper 33.
`
`4
`
`
`
`IPR2015-00902 (Patent 8,669,290)
`IPR2015-00903 (Patent 8,129,431)
`
`RESPECTFULLY SUBMITTED,
`
`ALSTON & BIRD LLP
`
`Date: May 19, 2015
`
`/s/Jitendra Malik
`
`Jitendra Malik (Reg. No. 55823)
`4721Emperor Boulevard, Suite 400
`Durham, North Carolina 27703
`Telephone: 919-862-2200
`Fax: 919-862-2260
`Jitty.Malik@alston.com
`
`Lead Counsel for Petitioner
`InnoPharma Licensing Inc., InnoPharma
`Licensing LLC, InnoPharma Inc.,
`InnoPharma LLC, Mylan
`Pharmaceuticals Inc., and Mylan Inc.
`
`5
`
`
`
`IPR2015-00902 (Patent 8,669,290)
`IPR2015-00903 (Patent 8,129,431)
`
`CERTIFICATION OF SERVICE
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned certifies that on the 19th day
`
`of May 2015, a complete copy of the foregoing “PROPOSED SCHEDULING
`
`ORDER” was served via email on counsel of record for the Patent Owner:
`
`Bryan C. Diner
`bryan.diner@finnegan.com
`
`M. Andrew Holtman
`andy.holtman@finnegan.com
`
`Justin J. Hasford
`justin.hasford@finnegan.com
`
`Jonathan R. Stroud
`jonathan.stroud@finnegan.com
`
`Courtesy copies of the foregoing were also served via email on counsel
`
`of record for the Petitioner in Metrics, Inc. v. Senju Pharmaceutical Co., Ltd.,
`
`IPR2014-01041 and IPR2014-01043 as follows:
`
`Patrick D. McPherson
`PDMcPherson@duanemorris.com
`
`Vincent L. Capuano
`VCapuano@duanemorris.com
`
`Respectfully submitted,
`
`Alston & Bird LLP
`
`By: /Jitendra Malik/
`
`6
`
`
`
`IPR2015-00902 (Patent 8,669,290)
`IPR2015-00903 (Patent 8,129,431)
`
`Jitendra Malik, Ph.D.
`Reg. No. 55823
`Alston & Bird LLP
`4721 Emperor Blvd., Suite 400
`Durham, NC 27703-8580
`jitty.malik@alston.com
`
`Bryan Skelton, Ph.D.
`Reg. No. 50893
`Alston & Bird LLP
`4721 Emperor Blvd., Suite 400
`Durham, NC 27703-8580
`bryan.skelton@alston.com
`
`Lance Soderstrom
`Reg. No. 65405
`Alston & Bird LLP
`90 Park Avenue
`15th Floor
`New York, NY 10016-1387
`lance.soderstrom@alston.com
`
`Attorneys for Petitioners
`InnoPharma Licensing, Inc.,
`InnoPharma Licensing LLC,
`InnoPharma Inc., InnoPharma
`LLC, Mylan Pharmaceuticals
`Inc., and Mylan Inc.
`
`7
`
`